|
(V858) |
Evaluation of Influencing factors on the fractional flow reserve and frequency of percutaneous coronary intervention in patients with coronary artery disease |
| |
|
O. Dörr, F. J. Hofmann, N. Forderer, S. Elekes, C. Liebetrau, T. Keller, J. Lorenz, N. F. Boeder, M. Bayer, A. Most, M. Dahmer, P. Bauer, H. Möllmann, L. Gaede, T. Bauer, C. W. Hamm, H. Nef (Gießen, Bad Nauheim, Dortmund) |
|
|
Diskussion |
|
(V859) |
Effects of real-time co-registration between angiography and optical coherence tomography on PCI strategy: results from OCT-core lab analysis of the OPTICO-Integration trial |
| |
|
L. Steinbeck, M. Riedel, B. Stähli, G. M. Fröhlich, A. Lauten, C. Skurk, H.-C. Mochmann, L. Lübking, U. Rauch-Kröhnert, R. Schnabel, D. Westermann, S. Blankenberg, U. Landmesser, D. Leistner (Berlin, Hamburg) |
|
|
Diskussion |
|
(V860) |
Safety and efficacy of “standardized” complex high-risk interventional procedures – a new pathway for protected percutaneous coronary interventions |
| |
|
F. Al-Rashid, R. A. Janosi, L. Johannsen, A. Krüger, P. Lüdike, M. Totzeck, A. Lind, P. Kahlert, T. Rassaf (Essen) |
|
|
Diskussion |
|
(V861) |
Evaluation of a self-apposing sirolimus eluting stent in routine clinical practice: results from the SIZING registry |
| |
|
H. Nef, O. Dörr, J. Wiebe, L. Gaede, M. Siry, J. Brachmann, H. Mudra, J. Rieber, S. Achenbach, A. Elsässer, A. Balland, H. Möllmann (Gießen, München, Dortmund, Memmingen, Coburg, Erlangen, Oldenburg; Paris, FR) |
|
|
Diskussion |
|
(V862) |
Clinical outcome of early versus late drug-eluting stent restenosis treated with drug-eluting balloon angioplasty: insights from the randomized ISAR DESIRE 3 and ISAR DESIRE 4 trials |
| |
|
T. Koch, N. Schacher, S. Cassese, R. Colleran, E. Xhepa, M. Abdel-Wahab, P. Hoppmann, M. Joner, B. Zrenner, T. Ibrahim, R. Tölg, H. Schunkert, K.-L. Laugwitz, A. Kastrati, R. Byrne, S. Kufner, für die Studiengruppe: ISAResearch Center (München, Bad Segeberg, Landshut) |
|
|
Diskussion |
|
(V863) |
Long-term outcomes after drug-eluting stents versus bare metal stents in saphenous vein graft lesions – 5-year follow-up of the ISAR CABG randomized trial |
| |
|
S. Kufner, R. Colleran, J. Mehilli, C. Rosenbeiger, M. Joner, P. Hoppmann, S. Schüpke, S. Cassese, M. Fusaro, M. Abdel-Wahab, F.-J. Neumann, G. Richardt, T. Ibrahim, H. Schunkert, K.-L. Laugwitz, A. Kastrati, R. Byrne, für die Studiengruppe: ISAResearch Center (München, Bad Segeberg, Bad Krozingen) |
|
|
Diskussion |